Rainer Riedl

Professor of Organic and Medicinal Chemistry

Zürcher Hochschule für Angewandte Wissenschaften

Switzerland

Research Interests

Explore related searches

Professors in Switzerland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Rainer Riedl is a Professor of Organic and Medicinal Chemistry at Zürcher Hochschule für Angewandte Wissenschaften in Switzerland. His research primarily focuses on the structural requirements of leucinostatin derivatives for antiprotozoal activity, and the development of novel protease inhibitors related to SARS-CoV-2. Recent publications include works on targeted protein degradation and the supramolecular organization of viral glycoproteins.

Articles (16)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (7)

Thomas Lemmin

Assistant Professor

University of Bern

SWITZERLAND

View details

Andreas Plückthun

University of Zurich

SWITZERLAND

View details

Dimitrios Fotiadis

Professor

University of Bern

SWITZERLAND

View details

Philippe Plattet

University of Bern

SWITZERLAND

View details

SILVIA GAZZOLA

Assistent Professor in Organic Chemistry

Università degli Studi di Modena e Reggio Emilia Dipartimento di Scienze della Vita

ITALY

View details

Pascal Mäser

Unit Head

Swiss Tropical and Public Health Institute

SWITZERLAND

View details

Simon Pot

Associate Professor of Veterinary Ophthalmology

Universität Zürich Vetsuisse-Fakultät

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Rainer Riedl

Research Interests

Explore related searches

Contact this professor

About

Articles (16)

Dissecting Structural Requirements of Leucinostatin A Derivatives for Antiprotozoal Activity and Mammalian Toxicity

Phthalimide derivatives as a new class of papain‐like protease inhibitors in SARS‐CoV‐2

Targeted protein degradation: current molecular targets, localization, and strategies

Structure and supramolecular organization of the canine distemper virus attachment glycoprotein

Structure of a hydrophobic leucinostatin derivative determined by host lattice display

Discovery of a Dual SENP1 and SENP2 Inhibitor

Tissue Inhibitor of Metalloproteinase (TIMP) Peptidomimetic as an Adjunctive Therapy for Infectious Keratitis

Antiprotozoal Structure–Activity Relationships of Synthetic Leucinostatin Derivatives and Elucidation of their Mode of Action

Antiprotozoische Struktur‐Aktivitäts‐Beziehungen von synthetischen Leucinostatin‐Derivaten und Aufklärung ihres Wirkprinzips

Back Cover: Antiprotozoal Structure–Activity Relationships of Synthetic Leucinostatin Derivatives and Elucidation of their Mode of Action (Angew. Chem. Int. Ed. 28/2021)

Rücktitelbild: Antiprotozoische Struktur‐Aktivitäts‐Beziehungen von synthetischen Leucinostatin‐Derivaten und Aufklärung ihres Wirkprinzips (Angew. Chem. 28/2021)

New perspectives in oral peptide delivery

Antiviral Screen against Canine Distemper Virus-Induced Membrane Fusion Activity

Challenges with matrix metalloproteinase inhibition and future drug discovery avenues

Isolation and Identification of Actinomycetes Strains from Switzerland and their Biotechnological Potential

Discovery of a Class of Potent and Selective Non‐competitive Sentrin‐Specific Protease 1 Inhibitors

Collaborators (7)

Thomas Lemmin

Andreas Plückthun

Dimitrios Fotiadis

Philippe Plattet

SILVIA GAZZOLA

Pascal Mäser

Simon Pot

Make your next move.